MYC and HIF in shaping immune response and immune metabolism

Cytokine Growth Factor Rev. 2017 Jun:35:63-70. doi: 10.1016/j.cytogfr.2017.03.004. Epub 2017 Mar 23.

Abstract

Upon antigen stimulation, quiescent naive T cells undergo a phase of cell mass accumulation followed by cell cycle entry, clonal expansion, differentiation into functional subsets and back again to a quiescent state as they develop into memory cells. The transitions between these distinct cellular states place unique metabolic demands on energy, redox and biosynthesis. To fulfill these demands, T cells switch back and forth between their primary catabolic pathways. While quiescent naive and memory T cells largely rely on the oxidation of fatty acids and glucose, active T cells rely on glycolysis and glutaminolysis to sustain cell growth, proliferation and differentiation. Beyond several key signaling kinase cascades, the hypoxia inducible factor 1 (HIF-1) and the proto-oncogene MYC, act alone or in concert, to coordinate T cell metabolic reprogramming, cell proliferation, functional differentiation and apoptosis, enabling a robust T cell-mediated adaptive immune response.

Keywords: HIF and MYC; Metabolic reprogramming; T lymphocytes.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity*
  • Animals
  • Apoptosis
  • Cell Differentiation
  • Cell Proliferation
  • Genes, myc*
  • Glucose / metabolism
  • Glycolysis
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
  • Lymphocyte Activation
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-myc / metabolism*
  • Signal Transduction
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism*

Substances

  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-myc
  • Glucose